Literature DB >> 4188283

Management of penicillamine nephropathy in Wilson's disease: a new chelating agent.

J M Walshe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4188283     DOI: 10.1016/s0140-6736(69)90940-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  26 in total

1.  Preparation of and clinical experiences with trien for the treatment of Wilson's disease in absolute intolerance of D-penicillamine.

Authors:  H Harders; E Cohnen
Journal:  Proc R Soc Med       Date:  1977

2.  Letter: Drugs for rare diseases.

Authors:  J M Walshe
Journal:  Br Med J       Date:  1975-09-20

3.  Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate.

Authors:  A Czlonkowska; J Gajda; M Rodo
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

4.  Bone demineralisation in a large cohort of Wilson disease patients.

Authors:  Karl Heinz Weiss; Mart Van de Moortele; Daniel Nils Gotthardt; Jan Pfeiffenberger; Jessica Seessle; Elena Ullrich; Evelien Gielen; Herman Borghs; Els Adriaens; Wolfgang Stremmel; Wouter Meersseman; Steven Boonen; David Cassiman
Journal:  J Inherit Metab Dis       Date:  2015-02-07       Impact factor: 4.982

5.  Thalidomide's long shadow.

Authors: 
Journal:  Br Med J       Date:  1976-11-13

Review 6.  Fair pricing of "old" orphan drugs: considerations for Canada's orphan drug policy.

Authors:  Eve A Roberts; Matthew Herder; Aidan Hollis
Journal:  CMAJ       Date:  2015-02-23       Impact factor: 8.262

Review 7.  Insights into the management of Wilson's disease.

Authors:  Mohmadshakil Kathawala; Gideon M Hirschfield
Journal:  Therap Adv Gastroenterol       Date:  2017-10-03       Impact factor: 4.409

8.  Chelating agents in medicine.

Authors: 
Journal:  Br Med J       Date:  1971-05-01

9.  Computer-based approach to chelation therapy: a theoretical study of some chelating agents for the selective removal of toxic metal ions from plasma.

Authors:  R P Agarwal; D D Perrin
Journal:  Agents Actions       Date:  1976-09

10.  Nephrotic syndrome induced by D-penicillamine therapy.

Authors:  P Jezersek; D Ferluga
Journal:  Int Urol Nephrol       Date:  1979       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.